Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up
Titel:
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up
Auteur:
Pothuri, Bhavana Brodsky, Allison L. Sparano, Joseph A. Blank, Stephanie V. Kim, Mimi Hershman, Dawn L. Tiersten, Amy Kiesel, Brian F. Beumer, Jan H. Liebes, Leonard Muggia, Franco